Nov 04, 2021 / 09:00PM GMT
Operator
Thank you for standing by, and welcome to the Salarius Pharmaceuticals' Third Quarter 2021 Corporate and Financial Results Conference Call. (Operator Instructions)
And I would now like to hand the conference over to Jason Rando of Tiberend Strategic Advisors. Please go ahead.
Jason Rando - Tiberend Strategic Advisors, Inc. - EVP and COO
Good afternoon, and thank you for joining Salarius Pharmaceuticals' 2021 third quarter financial and corporate results call. Earlier this afternoon, Salarius Pharmaceuticals issued a press release detailing its financial results for the three months ended September 30, 2021, which we encourage listeners to read. The press release can be found in the News section of salariuspharma.com.
Before beginning today's call, I would like to make the following statement. Today we will be making certain forward-looking statements about operating metrics, future expectations, plans, events and circumstances, including statements about our strategy, future operations and the development and effectiveness of our lead
Q3 2021 Salarius Pharmaceuticals Inc Earnings Call Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers